2011•Immunological JournalRequires access

The significance of blood serum thymidine kinase 1 in early screening of carcinoma in urinary system

Keqin Zhang

Open publisher page 0 citations

Abstract

We aimed to evaluate the value of serum thymidine kinase 1(STK1) in screening the neoplasms of the urinary system in early phase.We employed dot-blotting-enhanced chemiluminecence assay to detect the STK1 level in carcinoma group(including carcinoma of prostate,bladder carcinoma,and renal carcinoma),benign group,and normal group.The results showed that the STK1 level in the carcinoma group and the normal group was statistical different(P 0.05).And the neoplasm group and the benign group also showed statistical difference in STK1 level(P 0.05).The data imply that detecting STK1 has clinical value in screening of patients with carcinoma in the urinary system.

About this research paper

What this paper is about

We aimed to evaluate the value of serum thymidine kinase 1(STK1) in screening the neoplasms of the urinary system in early phase.We employed dot-blotting-enhanced chemiluminecence assay to detect the STK1 level in carcinoma group(including carcinoma of prostate,bladder carcinoma,and renal carcinoma),benign group,and normal group.The results showed that the STK1 level in the carcinoma group and the normal group was statistical different(P 0.05).And the neoplasm group and the benign group also showed statistical difference in STK1 level(P 0.05).The data imply that detecting STK1 has clinical value in screening of patients with carcinoma in the urinary system.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

We aimed to evaluate the value of serum thymidine kinase 1(STK1) in screening the neoplasms of the urinary system in early phase.We employed dot-blotting-enhanced chemiluminecence assay to detect the STK1 level in carcinoma group(including carcinoma of prostate,bladder carcinoma,and renal carcinoma),benign group,and normal group.The results showed that the STK1 level in the carcinoma group and the normal group was statistical different(P 0.05).And the neoplasm group and the benign group also showed statistical difference in STK1 level(P 0.05).The data imply that detecting STK1 has clinical value in screening of patients with carcinoma in the urinary system.

Key concepts: Urinary system, Carcinoma, Medicine, Internal medicine, Prostate, Urine, Thymidine kinase, Gastroenterology

Related papers

Back to paper searchBrowse research topicsOriginal source
The significance of blood serum thymidine kinase 1 in early screening of carcinoma in urinary system — Research Paper | ScholarLens